These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 37466726)

  • 1. Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum.
    Gittings LM; Alsop EB; Antone J; Singer M; Whitsett TG; Sattler R; Van Keuren-Jensen K
    Acta Neuropathol; 2023 Sep; 146(3):433-450. PubMed ID: 37466726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurons selectively targeted in frontotemporal dementia reveal early stage TDP-43 pathobiology.
    Nana AL; Sidhu M; Gaus SE; Hwang JL; Li L; Park Y; Kim EJ; Pasquini L; Allen IE; Rankin KP; Toller G; Kramer JH; Geschwind DH; Coppola G; Huang EJ; Grinberg LT; Miller BL; Seeley WW
    Acta Neuropathol; 2019 Jan; 137(1):27-46. PubMed ID: 30511086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
    Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
    Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
    Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanisms of Neurodegeneration Related to
    Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
    Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of cryptic splicing associated with TDP-43 depletion.
    Humphrey J; Emmett W; Fratta P; Isaacs AM; Plagnol V
    BMC Med Genomics; 2017 May; 10(1):38. PubMed ID: 28549443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.
    Umoh ME; Dammer EB; Dai J; Duong DM; Lah JJ; Levey AI; Gearing M; Glass JD; Seyfried NT
    EMBO Mol Med; 2018 Jan; 10(1):48-62. PubMed ID: 29191947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.
    Beckers J; Tharkeshwar AK; Van Damme P
    Autophagy; 2021 Nov; 17(11):3306-3322. PubMed ID: 33632058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The most prevalent genetic cause of ALS-FTD, C9orf72 synergizes the toxicity of ATXN2 intermediate polyglutamine repeats through the autophagy pathway.
    Ciura S; Sellier C; Campanari ML; Charlet-Berguerand N; Kabashi E
    Autophagy; 2016 Aug; 12(8):1406-8. PubMed ID: 27245636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
    Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
    Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: Towards therapeutic targets and biomarkers.
    Akiyama T; Koike Y; Petrucelli L; Gitler AD
    Clin Transl Med; 2022 May; 12(5):e818. PubMed ID: 35567447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD.
    Irwin KE; Jasin P; Braunstein KE; Sinha IR; Garret MA; Bowden KD; Chang K; Troncoso JC; Moghekar A; Oh ES; Raitcheva D; Bartlett D; Miller T; Berry JD; Traynor BJ; Ling JP; Wong PC
    Nat Med; 2024 Feb; 30(2):382-393. PubMed ID: 38278991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic gain-of-function mechanisms in
    Beckers J; Van Damme P
    Autophagy; 2024 Sep; 20(9):2102-2104. PubMed ID: 38615685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD.
    Moore S; Alsop E; Lorenzini I; Starr A; Rabichow BE; Mendez E; Levy JL; Burciu C; Reiman R; Chew J; Belzil VV; W Dickson D; Robertson J; Staats KA; Ichida JK; Petrucelli L; Van Keuren-Jensen K; Sattler R
    Acta Neuropathol; 2019 Jul; 138(1):49-65. PubMed ID: 30945056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD.
    Seddighi S; Qi YA; Brown AL; Wilkins OG; Bereda C; Belair C; Zhang YJ; Prudencio M; Keuss MJ; Khandeshi A; Pickles S; Kargbo-Hill SE; Hawrot J; Ramos DM; Yuan H; Roberts J; Sacramento EK; Shah SI; Nalls MA; Colón-Mercado JM; Reyes JF; Ryan VH; Nelson MP; Cook CN; Li Z; Screven L; Kwan JY; Mehta PR; Zanovello M; Hallegger M; Shantaraman A; Ping L; Koike Y; Oskarsson B; Staff NP; Duong DM; Ahmed A; Secrier M; Ule J; Jacobson S; Reich DS; Rohrer JD; Malaspina A; Dickson DW; Glass JD; Ori A; Seyfried NT; Maragkakis M; Petrucelli L; Fratta P; Ward ME
    Sci Transl Med; 2024 Feb; 16(734):eadg7162. PubMed ID: 38277467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial Cell Dysfunction in
    Ghasemi M; Keyhanian K; Douthwright C
    Cells; 2021 Jan; 10(2):. PubMed ID: 33525344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit.
    Sattler R; Traynor BJ; Robertson J; Van Den Bosch L; Barmada SJ; Svendsen CN; Disney MD; Gendron TF; Wong PC; Turner MR; Boxer A; Babu S; Benatar M; Kurnellas M; Rohrer JD; Donnelly CJ; Bustos LM; Van Keuren-Jensen K; Dacks PA; Sabbagh MN;
    Neurol Ther; 2023 Dec; 12(6):1821-1843. PubMed ID: 37847372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis.
    Diekstra FP; Van Deerlin VM; van Swieten JC; Al-Chalabi A; Ludolph AC; Weishaupt JH; Hardiman O; Landers JE; Brown RH; van Es MA; Pasterkamp RJ; Koppers M; Andersen PM; Estrada K; Rivadeneira F; Hofman A; Uitterlinden AG; van Damme P; Melki J; Meininger V; Shatunov A; Shaw CE; Leigh PN; Shaw PJ; Morrison KE; Fogh I; Chiò A; Traynor BJ; Czell D; Weber M; Heutink P; de Bakker PI; Silani V; Robberecht W; van den Berg LH; Veldink JH
    Ann Neurol; 2014 Jul; 76(1):120-33. PubMed ID: 24931836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.
    Chou CC; Zhang Y; Umoh ME; Vaughan SW; Lorenzini I; Liu F; Sayegh M; Donlin-Asp PG; Chen YH; Duong DM; Seyfried NT; Powers MA; Kukar T; Hales CM; Gearing M; Cairns NJ; Boylan KB; Dickson DW; Rademakers R; Zhang YJ; Petrucelli L; Sattler R; Zarnescu DC; Glass JD; Rossoll W
    Nat Neurosci; 2018 Feb; 21(2):228-239. PubMed ID: 29311743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C9orf72 Gene Expression in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
    Shpilyukova YA; Fedotova EY; Abramycheva NY; Kochergin IA; Zakroyshchikova IV; Zakharova MN; Illarioshkin SN
    Bull Exp Biol Med; 2020 Sep; 169(5):673-676. PubMed ID: 32990847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.